ImmunityBio, Inc.(纳斯达克代码:IBRX)宣布,将于2026年3月3日(星期二)举行2025财年财务业绩发布会。届时,公司管理层将详细介绍业务最新进展,并对全年财务数据进行全面解读。此次会议将为投资者提供深入了解公司战略布局与未来发展动向的重要窗口。
ImmunityBio, Inc.(纳斯达克代码:IBRX)宣布,将于2026年3月3日(星期二)举行2025财年财务业绩发布会。届时,公司管理层将详细介绍业务最新进展,并对全年财务数据进行全面解读。此次会议将为投资者提供深入了解公司战略布局与未来发展动向的重要窗口。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.